Home/Filings/4/0001213900-23-043531
4//SEC Filing

Ryweck Daniel E. 4

Accession 0001213900-23-043531

CIK 0001514183other

Filed

May 25, 8:00 PM ET

Accepted

May 26, 4:17 PM ET

Size

4.8 KB

Accession

0001213900-23-043531

Insider Transaction Report

Form 4
Period: 2023-05-26
Ryweck Daniel E.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2023-05-26$2.13/sh+1,000$2,1265,000 total

Documents

1 file

Issuer

Silo Pharma, Inc.

CIK 0001514183

Entity typeother

Related Parties

1
  • filerCIK 0001652799

Filing Metadata

Form type
4
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:17 PM ET
Size
4.8 KB